1. Risk of tuberculosis following HIV seroconversion in high-income countries
- Author
-
Sara Lodi, Sophie Abgrall, Roberto Muga, Charles S. Morrison, Enrico Girardi, Kholoud Porter, Hansjakob Furrer, Caroline A. Sabin, Julia del Amo, Antonella d'Arminio Monforte, AII - Amsterdam institute for Infection and Immunity, APH - Amsterdam Public Health, Infectious diseases, Epidemiology and Data Science, Other departments, and Experimental Immunology
- Subjects
Male ,Pulmonary and Respiratory Medicine ,Cart ,Canada ,Pediatrics ,medicine.medical_specialty ,Time Factors ,Tuberculosis ,Disease ,03 medical and health sciences ,0302 clinical medicine ,Acquired immunodeficiency syndrome (AIDS) ,Risk Factors ,HIV Seropositivity ,medicine ,Humans ,Poisson Distribution ,030212 general & internal medicine ,Seroconversion ,Africa South of the Sahara ,0303 health sciences ,AIDS-Related Opportunistic Infections ,Coinfection ,030306 microbiology ,business.industry ,Developed Countries ,Incidence ,Incidence (epidemiology) ,Australia ,virus diseases ,medicine.disease ,CD4 Lymphocyte Count ,3. Good health ,Europe ,Anti-Retroviral Agents ,Immunology ,Cohort ,RNA, Viral ,Female ,business - Abstract
Background Few data exist on tuberculosis (TB) incidence according to time from HIV seroconversion in high-income countries and whether rates following initiation of a combination of antiretroviral treatments (cARTs) differ from those soon after seroconversion. Methods Data on individuals with well estimated dates of HIV seroconversion were used to analyse post-seroconversion TB rates, ending at the earliest of 1 January 1997, death or last clinic visit. TB rates were also estimated following cART initiation, ending at the earliest of death or last clinic visit. Poisson models were used to examine the effect of current and past level of immunosuppression on TB risk after cART initiation. Results Of 19 815 individuals at risk during 1982–1996, TB incidence increased from 5.89/1000 person-years (PY) (95% CI 3.77 to 8.76) in the first year after seroconversion to 10.56 (4.83 to 20.04, p=0.01) at 10 years. Among 11 178 TB-free individuals initiating cART, the TB rate in the first year after cART initiation was 4.23/1000 PY (3.07 to 5.71) and dropped thereafter, remaining constant from year 2 onwards averaging at 1.64/1000 PY (1.29 to 2.05). Current CD4 count was inversely associated with TB rates, while nadir CD4 count was not associated with TB rates after adjustment for current CD4 count, HIV-RNA at cART initiation. Conclusions TB risk increases with duration of HIV infection in the absence of cART. Following cART initiation, TB incidence rates were lower than levels immediately following seroconversion. Implementation of current recommendations to prevent TB in early HIV infection could be beneficial.
- Published
- 2012
- Full Text
- View/download PDF